TY  - GEN
AU  - Hwang,C
AU  - Sanda,M G
TI  - Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy
SN  - 1464-8431
PY  - 2002///0102
KW  - Adenocarcinoma
KW  - immunology
KW  - Animals
KW  - Antibodies, Viral
KW  - Antigen Presentation
KW  - Antigens, Neoplasm
KW  - genetics
KW  - Autoimmunity
KW  - B7-1 Antigen
KW  - Canarypox virus
KW  - Cancer Vaccines
KW  - administration & dosage
KW  - Cell Compartmentation
KW  - Clinical Trials as Topic
KW  - Combined Modality Therapy
KW  - Cytokines
KW  - DNA, Recombinant
KW  - Fowlpox virus
KW  - Genetic Therapy
KW  - methods
KW  - Genetic Vectors
KW  - Humans
KW  - Immunotherapy
KW  - Immunotherapy, Active
KW  - Male
KW  - Mice
KW  - Mice, Transgenic
KW  - Neoplasm Metastasis
KW  - Neoplasm Transplantation
KW  - Poxviridae
KW  - Promoter Regions, Genetic
KW  - Prostatic Neoplasms
KW  - Rats
KW  - Recombinant Fusion Proteins
KW  - Salvage Therapy
KW  - Self Tolerance
KW  - Smallpox Vaccine
KW  - Species Specificity
KW  - Vaccination
KW  - Vaccinia
KW  - Viral Vaccines
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
ER  -